ES2757847T3 - Método para detectar y evaluar la hiperemia reactiva mediante pletismografía segmentaria - Google Patents
Método para detectar y evaluar la hiperemia reactiva mediante pletismografía segmentaria Download PDFInfo
- Publication number
- ES2757847T3 ES2757847T3 ES10783706T ES10783706T ES2757847T3 ES 2757847 T3 ES2757847 T3 ES 2757847T3 ES 10783706 T ES10783706 T ES 10783706T ES 10783706 T ES10783706 T ES 10783706T ES 2757847 T3 ES2757847 T3 ES 2757847T3
- Authority
- ES
- Spain
- Prior art keywords
- cuff
- pressure
- curve
- compliance
- area
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 46
- 206010020565 Hyperaemia Diseases 0.000 title claims abstract description 32
- 208000022064 reactive hyperemia Diseases 0.000 title claims abstract description 20
- 230000000544 hyperemic effect Effects 0.000 claims abstract description 32
- 230000008859 change Effects 0.000 claims abstract description 24
- 230000007423 decrease Effects 0.000 claims abstract description 5
- 230000035488 systolic blood pressure Effects 0.000 claims description 8
- 238000012417 linear regression Methods 0.000 claims description 2
- 206010048554 Endothelial dysfunction Diseases 0.000 description 59
- 230000008694 endothelial dysfunction Effects 0.000 description 59
- 238000005259 measurement Methods 0.000 description 28
- 230000036772 blood pressure Effects 0.000 description 20
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 19
- 238000011282 treatment Methods 0.000 description 18
- 201000010099 disease Diseases 0.000 description 17
- 210000001367 artery Anatomy 0.000 description 12
- 201000011461 pre-eclampsia Diseases 0.000 description 12
- 238000001914 filtration Methods 0.000 description 11
- 208000024172 Cardiovascular disease Diseases 0.000 description 10
- 230000006870 function Effects 0.000 description 10
- 230000002093 peripheral effect Effects 0.000 description 10
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 201000001320 Atherosclerosis Diseases 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 5
- 206010020772 Hypertension Diseases 0.000 description 4
- 208000006011 Stroke Diseases 0.000 description 4
- 230000004872 arterial blood pressure Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 238000012544 monitoring process Methods 0.000 description 4
- 230000000541 pulsatile effect Effects 0.000 description 4
- 208000019553 vascular disease Diseases 0.000 description 4
- 206010019280 Heart failures Diseases 0.000 description 3
- 208000035150 Hypercholesterolemia Diseases 0.000 description 3
- 208000018262 Peripheral vascular disease Diseases 0.000 description 3
- 230000004219 arterial function Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 210000005242 cardiac chamber Anatomy 0.000 description 3
- 230000000747 cardiac effect Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000008753 endothelial function Effects 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 230000000391 smoking effect Effects 0.000 description 3
- 210000002460 smooth muscle Anatomy 0.000 description 3
- 230000004580 weight loss Effects 0.000 description 3
- 206010003658 Atrial Fibrillation Diseases 0.000 description 2
- 206010007559 Cardiac failure congestive Diseases 0.000 description 2
- 208000010228 Erectile Dysfunction Diseases 0.000 description 2
- 208000004930 Fatty Liver Diseases 0.000 description 2
- 206010016654 Fibrosis Diseases 0.000 description 2
- 208000005176 Hepatitis C Diseases 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- 206010040070 Septic Shock Diseases 0.000 description 2
- 230000008321 arterial blood flow Effects 0.000 description 2
- 230000007211 cardiovascular event Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000007882 cirrhosis Effects 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 238000004590 computer program Methods 0.000 description 2
- 238000005094 computer simulation Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 238000013399 early diagnosis Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000003038 endothelium Anatomy 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 208000002672 hepatitis B Diseases 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 238000007620 mathematical function Methods 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 208000008338 non-alcoholic fatty liver disease Diseases 0.000 description 2
- 206010053219 non-alcoholic steatohepatitis Diseases 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- 208000009206 Abruptio Placentae Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 108010074051 C-Reactive Protein Proteins 0.000 description 1
- 102100032752 C-reactive protein Human genes 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 201000005624 HELLP Syndrome Diseases 0.000 description 1
- 208000031886 HIV Infections Diseases 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 206010021138 Hypovolaemic shock Diseases 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 206010042434 Sudden death Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 235000021074 carbohydrate intake Nutrition 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 1
- 230000001447 compensatory effect Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000002641 glycemic effect Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 208000007475 hemolytic anemia Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000007903 liver failure Diseases 0.000 description 1
- 231100000835 liver failure Toxicity 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 201000008532 placental abruption Diseases 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 201000001474 proteinuria Diseases 0.000 description 1
- 230000010349 pulsation Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000004648 relaxation of smooth muscle Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000000276 sedentary effect Effects 0.000 description 1
- 230000036303 septic shock Effects 0.000 description 1
- 206010040560 shock Diseases 0.000 description 1
- 230000005586 smoking cessation Effects 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000006441 vascular event Effects 0.000 description 1
- 230000006438 vascular health Effects 0.000 description 1
- 230000006442 vascular tone Effects 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/026—Measuring blood flow
- A61B5/0295—Measuring blood flow using plethysmography, i.e. measuring the variations in the volume of a body part as modified by the circulation of blood therethrough, e.g. impedance plethysmography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/02007—Evaluating blood vessel condition, e.g. elasticity, compliance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/02141—Details of apparatus construction, e.g. pump units or housings therefor, cuff pressurising systems, arrangements of fluid conduits or circuits
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/022—Measuring pressure in heart or blood vessels by applying pressure to close blood vessels, e.g. against the skin; Ophthalmodynamometers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/022—Measuring pressure in heart or blood vessels by applying pressure to close blood vessels, e.g. against the skin; Ophthalmodynamometers
- A61B5/0225—Measuring pressure in heart or blood vessels by applying pressure to close blood vessels, e.g. against the skin; Ophthalmodynamometers the pressure being controlled by electric signals, e.g. derived from Korotkoff sounds
- A61B5/02255—Measuring pressure in heart or blood vessels by applying pressure to close blood vessels, e.g. against the skin; Ophthalmodynamometers the pressure being controlled by electric signals, e.g. derived from Korotkoff sounds the pressure being controlled by plethysmographic signals, e.g. derived from optical sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4842—Monitoring progression or stage of a disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Physics & Mathematics (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Physiology (AREA)
- Ophthalmology & Optometry (AREA)
- Hematology (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21336909P | 2009-06-02 | 2009-06-02 | |
| PCT/US2010/001605 WO2010141081A2 (en) | 2009-06-02 | 2010-06-02 | Method and device for detecting and assessing reactive hyperemia using segmental plethysmography |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2757847T3 true ES2757847T3 (es) | 2020-04-30 |
Family
ID=43221023
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES10783706T Active ES2757847T3 (es) | 2009-06-02 | 2010-06-02 | Método para detectar y evaluar la hiperemia reactiva mediante pletismografía segmentaria |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US8708921B2 (enExample) |
| EP (1) | EP2437656B1 (enExample) |
| JP (1) | JP5689116B2 (enExample) |
| CN (2) | CN102481106A (enExample) |
| AU (1) | AU2010257159B2 (enExample) |
| CA (2) | CA2995279C (enExample) |
| ES (1) | ES2757847T3 (enExample) |
| WO (1) | WO2010141081A2 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9788733B2 (en) | 2009-06-02 | 2017-10-17 | Cordex Systems, Inc. | Method and device for detecting and assessing reactive hyperemia using segmental plethysmography |
| JP5689116B2 (ja) | 2009-06-02 | 2015-03-25 | ウィット, マイケル, デイヴィッドWHITT, Michael, David | 分節プレチスモグラフィを用いて反応性充血を検出及び評価する方法及び機器 |
| US20180042490A1 (en) * | 2009-06-02 | 2018-02-15 | Cordex Systems, Inc | Method and device for detecting and assessing reactive hyperemia using segmental plethysmography |
| US20170000355A1 (en) * | 2009-06-12 | 2017-01-05 | Everist Genomics, Inc. | System and method of assessing endothelial function |
| US20140170069A1 (en) * | 2011-05-05 | 2014-06-19 | Cedars-Sinai Medical Center | Assessment of coronary heart disease with carbon dioxide |
| AU2012250539A1 (en) | 2011-05-05 | 2013-12-19 | Cedars-Sinai Medical Center | Assessment of coronary heart disease with carbon dioxide |
| US11129911B2 (en) | 2011-05-05 | 2021-09-28 | Cedars-Sinai Medical Center | Assessment of coronary heart disease with carbon dioxide |
| WO2014160515A1 (en) * | 2013-03-13 | 2014-10-02 | Everist Genomics, Inc. | Flow-mediated dilation to determine vascular age |
| US20150080747A1 (en) * | 2013-06-28 | 2015-03-19 | Cardiovascular Systems, Inc. | Devices, systems and methods for locally measuring biological conduit and/or lesion compliance, opposition force and inner diameter of a biological conduit |
| WO2015021078A1 (en) | 2013-08-05 | 2015-02-12 | Cedars-Sinai Medical Center | Methods for reducing ischemia-reperfusion injury |
| US20170065189A1 (en) * | 2014-03-03 | 2017-03-09 | Promedica Health System, Inc. | Systems and methods for performing an objective analysis of air plethysmography waveform |
| WO2015138026A1 (en) | 2014-03-11 | 2015-09-17 | Cordex Systems, Inc. | Method and device for detecting and assessing reactive hyperemia using segmental plethysmography |
| US10945612B2 (en) | 2014-04-03 | 2021-03-16 | The Regents Of The University Of California | Assessing endothelial function using a blood pressure cuff |
| EP3185767A1 (en) * | 2014-08-28 | 2017-07-05 | Koninklijke Philips N.V. | Method for oscillatory non-invasive blood pressure (nibp) measurement and control unit for an nibp apparatus |
| US10939832B2 (en) * | 2015-02-11 | 2021-03-09 | Microlife Intellectual Property Gmbh | Device and method for measuring blood pressure and for indication of the presence of atrial fibrillation |
| JP6482412B2 (ja) | 2015-07-01 | 2019-03-13 | 浜松ホトニクス株式会社 | 粘弾特性取得装置、粘弾特性取得方法、粘弾特性取得プログラム、及びそのプログラムを記録する記録媒体 |
| JP2018525106A (ja) * | 2015-08-14 | 2018-09-06 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 血圧計カフを使用して内皮機能を評価し較正済みｕＦＭＤデータを提供すること |
| US11284842B2 (en) | 2015-12-23 | 2022-03-29 | Koninklijke Philips N.V. | Method of assessing the reliability of a blood pressure measurement and an apparatus for implementing the same |
| JP6627502B2 (ja) * | 2015-12-28 | 2020-01-08 | オムロンヘルスケア株式会社 | 電子血圧計 |
| US11253522B2 (en) | 2018-04-28 | 2022-02-22 | The Regents Of The University Of California | Cancer treatment targeted to tumor adaptive responses to protein synthesis stress |
| EP3964124A1 (en) * | 2020-09-02 | 2022-03-09 | Koninklijke Philips N.V. | Method and apparatus for estimating the reliability of cardiac output measurements |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4984577A (en) * | 1989-03-20 | 1991-01-15 | Hewlett-Packard Company | Oscillometric non-invasive method for measuring blood pressure and apparatus for automated oscillometric blood pressure measuring |
| US5417220A (en) * | 1989-12-20 | 1995-05-23 | Critikon, Inc. | Peripheral arterial monitoring instruments |
| EP0588982B1 (en) * | 1991-06-12 | 2001-03-21 | Florida Atlantic University Research Corp. | Detecting atherosclerosis in humans |
| JPH06319707A (ja) * | 1993-05-13 | 1994-11-22 | Omron Corp | 電子血圧計 |
| US6309359B1 (en) * | 1998-06-01 | 2001-10-30 | Michael D. Whitt | Method and apparatus for noninvasive determination of peripheral arterial lumenal area |
| US6152881A (en) * | 1999-03-29 | 2000-11-28 | Vasocor, Inc. | Calibrated measurement of blood vessels and endothelium after reactive hyperemia and method therefor |
| US6338719B1 (en) * | 2000-06-12 | 2002-01-15 | Rutgers, The State University Of New Jersey | Method and system for detecting vascular conditions using an occlusive arm cuff plethysmograph |
| JP3393432B2 (ja) * | 2000-09-06 | 2003-04-07 | オムロン株式会社 | 電子血圧計 |
| WO2002034105A2 (en) * | 2000-10-23 | 2002-05-02 | Itamar Medical Ltd. | Non-invasive endothelial activity evaluation |
| JP3590583B2 (ja) * | 2000-12-28 | 2004-11-17 | フクダ電子株式会社 | 血管内皮機能測定装置 |
| JP2003284696A (ja) * | 2002-03-28 | 2003-10-07 | Omron Corp | 電子血圧計および電子血圧計の血圧測定方法 |
| US6733461B2 (en) * | 2002-08-01 | 2004-05-11 | Hypertension Diagnostics, Inc. | Methods and apparatus for measuring arterial compliance, improving pressure calibration, and computing flow from pressure data |
| US20070225614A1 (en) * | 2004-05-26 | 2007-09-27 | Endothelix, Inc. | Method and apparatus for determining vascular health conditions |
| US7390303B2 (en) * | 2003-09-30 | 2008-06-24 | Ehud Dafni | Assessment of vascular dilatation |
| WO2005069740A2 (en) * | 2004-01-27 | 2005-08-04 | Cardiometer Ltd. | Method and system for cardiovascular system diagnosis |
| JP4629430B2 (ja) * | 2004-12-28 | 2011-02-09 | フクダ電子株式会社 | 血管内皮機能測定装置 |
| US8197416B1 (en) * | 2005-08-19 | 2012-06-12 | Ravi Shankar | Pulsatile measurement of cardiac malfunction conditions |
| US7674231B2 (en) * | 2005-08-22 | 2010-03-09 | Massachusetts Institute Of Technology | Wearable pulse wave velocity blood pressure sensor and methods of calibration thereof |
| JP4144807B2 (ja) * | 2005-11-21 | 2008-09-03 | 株式会社志成データム | 血管硬化度測定装置および血圧測定装置 |
| RU2309668C1 (ru) * | 2006-02-20 | 2007-11-10 | Александр Сергеевич Парфенов | Способ неинвазивного определения функции эндотелия и устройство для его осуществления |
| JP5176020B2 (ja) * | 2007-03-02 | 2013-04-03 | 国立大学法人 名古屋工業大学 | 生体内管腔体評価装置 |
| JP2008272387A (ja) * | 2007-03-30 | 2008-11-13 | Hiroshima Univ | 血管粘弾性測定装置、血管粘弾性測定方法、プログラム、コンピュータ読み取り可能な記録媒体、大規模集積回路及びｆｐｇａ |
| JP5363795B2 (ja) | 2008-04-14 | 2013-12-11 | 国立大学法人広島大学 | 血管内皮機能評価装置及び血管内皮機能評価方法 |
| JP5689116B2 (ja) * | 2009-06-02 | 2015-03-25 | ウィット, マイケル, デイヴィッドWHITT, Michael, David | 分節プレチスモグラフィを用いて反応性充血を検出及び評価する方法及び機器 |
-
2010
- 2010-06-02 JP JP2012513936A patent/JP5689116B2/ja active Active
- 2010-06-02 EP EP10783706.4A patent/EP2437656B1/en active Active
- 2010-06-02 CA CA2995279A patent/CA2995279C/en active Active
- 2010-06-02 WO PCT/US2010/001605 patent/WO2010141081A2/en not_active Ceased
- 2010-06-02 CN CN201080024509XA patent/CN102481106A/zh active Pending
- 2010-06-02 CN CN201710123346.4A patent/CN107028601A/zh active Pending
- 2010-06-02 ES ES10783706T patent/ES2757847T3/es active Active
- 2010-06-02 CA CA2763890A patent/CA2763890C/en active Active
- 2010-06-02 US US12/792,504 patent/US8708921B2/en active Active
- 2010-06-02 AU AU2010257159A patent/AU2010257159B2/en active Active
-
2014
- 2014-03-11 US US14/204,678 patent/US9668662B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20140194754A1 (en) | 2014-07-10 |
| AU2010257159B2 (en) | 2015-03-26 |
| JP5689116B2 (ja) | 2015-03-25 |
| US9668662B2 (en) | 2017-06-06 |
| AU2010257159A1 (en) | 2012-01-19 |
| WO2010141081A2 (en) | 2010-12-09 |
| JP2012528671A (ja) | 2012-11-15 |
| CN107028601A (zh) | 2017-08-11 |
| US8708921B2 (en) | 2014-04-29 |
| EP2437656B1 (en) | 2019-11-20 |
| CA2763890A1 (en) | 2010-12-09 |
| WO2010141081A3 (en) | 2011-03-24 |
| CA2763890C (en) | 2018-04-03 |
| CA2995279C (en) | 2020-12-15 |
| CA2995279A1 (en) | 2010-12-09 |
| CN102481106A (zh) | 2012-05-30 |
| US20100305459A1 (en) | 2010-12-02 |
| EP2437656A2 (en) | 2012-04-11 |
| EP2437656A4 (en) | 2012-05-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2757847T3 (es) | Método para detectar y evaluar la hiperemia reactiva mediante pletismografía segmentaria | |
| Poon et al. | Cuff-less and noninvasive measurements of arterial blood pressure by pulse transit time | |
| Chung et al. | Non-invasive continuous blood pressure monitoring: a review of current applications | |
| US10226186B2 (en) | Method and device for detecting and assessing reactive hyperemia using segmental plethysmography | |
| US20030135124A1 (en) | Methods, apparatus and articles-of-manufacture for noninvasive measurement and monitoring of peripheral blood flow, perfusion, cardiac output biophysic stress and cardiovascular condition | |
| CN102469947B (zh) | 使用信号渡越时间来监控心血管状况 | |
| ES2715102T3 (es) | Método y dispositivo para diagnosticar el potencial de desarrollar una enfermedad cardiovascular | |
| ES2910070T3 (es) | Método y dispositivo para detectar y evaluar la hiperemia reactiva mediante pletismografía segmentaria | |
| US20180042490A1 (en) | Method and device for detecting and assessing reactive hyperemia using segmental plethysmography | |
| Balestrieri et al. | Calibration of automated non invasive blood pressure measurement devices | |
| AU2015202799A1 (en) | Method And Device For Detecting And Assessing Reactive Hyperemia Using Segmental Plethysmography | |
| Johnston et al. | Noninvasive measurement of systolic pressure slope: a reliable index of the presence of peripheral arterial occlusive disease | |
| Sadaghiani et al. | Validation of the Saadat NIBP module according to the ANSI/AAMI-SP10 protocol | |
| HK1243610A1 (en) | Method and device for assessing reactive hyperemia | |
| HK1235645A1 (en) | Method and device for detecting and assessing reactive hyperemia using segmental plethysmography | |
| HK1235645B (zh) | 使用节段体积描记术检测和评估反应性充血的方法和装置 | |
| Rodríguez Árbol | Influencias simpáticas de la defensa cardiaca: Análisis de las variaciones fásicas en el periodo de pre-eyección |